| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| atomoxetine | nmda receptor | small molecule | NA | drugbank | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | blocker |
| atomoxetine | nmda receptor | small molecule | NA | drugbank | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | blocker |
| atomoxetine | nmda receptor | small molecule | NA | drugbank | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | blocker |
| atomoxetine | nmda receptor | small molecule | NA | drugbank | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | blocker |
| atomoxetine | nmda receptor | small molecule | NA | drugbank | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | blocker |
| atomoxetine | nmda receptor | small molecule | NA | drugbank | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | blocker |
| atomoxetine | nmda receptor | small molecule | NA | drugbank | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | blocker |
| atomoxetine | g protein-activated inward rectifier potassium channel 1 | small molecule | NA | drugbank | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| atomoxetine | kappa-type opioid receptor | small molecule | NA | drugbank | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | partial agonist |
| atomoxetine | norepinephrine transporter | NA | Successful target | TTD , DGIDB | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
4.42 | approved | unknown |
| atomoxetine | norepinephrine transporter | NA | Successful target | TTD , DGIDB | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
4.42 | approved | inhibitor |
| atomoxetine | sodium-dependent noradrenaline transporter | small molecule | NA | drugbank , DGIDB | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
4.42 | approved | inhibitor |
| atomoxetine | sodium-dependent serotonin transporter | small molecule | NA | drugbank , DGIDB | Attention deficit hyperactivity disorder[MeSHID:D001289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.86 | approved | binder,inhibitor |
| click here to return to the previous page | ||||||||